BeiGene (Shanghai) Co., Ltd. Employment contractEmployment Agreement • February 28th, 2022 • BeiGene, Ltd. • Pharmaceutical preparations
CERTAIN INFORMATION (INDICATED BY “[…***…]”) AND SCHEDULES HAVE BEEN EXCLUDED FROM THIS AGREEMENT BECAUSE SUCH INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. OPTION, COLLABORATION AND LICENSE AGREEMENT...Option, Collaboration and License Agreement • February 28th, 2022 • BeiGene, Ltd. • Pharmaceutical preparations • New York
This OPTION, COLLABORATION AND LICENSE AGREEMENT (this “Agreement”) is entered into as of December 19, 2021 (the “Execution Date”) by and between BeiGene Switzerland GmbH, a Swiss corporation (“BeiGene”), and Novartis Pharma AG, a Swiss corporation (“Novartis”). BeiGene and Novartis are each referred to herein by name, or as a “Party” or, collectively, as the “Parties.”
